CIBC Private Wealth Group
MIRM icon

CIBC Private Wealth Group’s Mirum Pharmaceuticals MIRM Stock Holding History

CIBC Private Wealth Group’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$31.7K Buy
+401
New +$28.8K ﹤0.01% 1975
2024
Q2 		– Sell
-10
Closed -$255 – 3240
2024
Q1 		$255 Buy
+10
New +$275 ﹤0.01% 2976

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CIBC Private Wealth Group's MIRM Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Mirum Pharmaceuticals (MIRM) in Q4 2025: 401 shares worth $31.7K. The stake represents ﹤0.01% of the portfolio and ranks #1975 among its holdings. This is a return to the name: CIBC Private Wealth Group previously reported a position in MIRM as recently as Q1 2024.

CIBC Private Wealth Group first reported a position in MIRM in Q1 2024 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

  • CIBC Private Wealth Group held 401 shares of Mirum Pharmaceuticals worth $31.7K as of Q4 2025.
  • Mirum Pharmaceuticals was a new CIBC Private Wealth Group position in Q4 2025.
  • Mirum Pharmaceuticals made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1975 holding.
  • CIBC Private Wealth Group first reported a position in Mirum Pharmaceuticals in Q1 2024 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.